Search Results for "Clobetasol 0 05 For The Scalp"
Matching Channels
Xeroderma, literally meaning "dry skin", is a condition involving the integumentary system, which in most cases can safely be treated with emollients and/or moisturizers. Xeroderma occurs...
Matching News
FDA approves Perrigo's ANDA for clobetasol propionate shampoo
Perrigo Company today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for clobetasol propionate shampoo, 0.05%, the ge...
Perrigo Receives FDA Approval And Commences Launch Of Clobetasol Propionate Shampoo, 0.05%
ALLEGAN, Mich., Aug. 9, 2012 /- Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug app...
Hi-Tech Pharmacal to buy Cormax treatment
Hi-Tech Pharmacal (NASDAQ:HITK) inked a deal with Watson Laboratories on Monday to buy exclusive rights to Cormax, a topical solution to treat scalp conditions.Cormax, a branded version of clobetasol...
FDA approves Sorilux for scalp psoriasis
The Food and Drug Administration has approved Sorilux Foam 0.005 percent for the topical treatment of plaque psoriasis of the scalp.
Rare condition causes scalp thickening
An unusual condition in which excessive growth of the scalp results in ridges and furrows resembling the brain’s surface has been demonstrated in a case study.
Histological analysis of all scalp cysts is counsel of perfection
In their Minerva article about a malignant pilar tumour Khan and Dharma state that “histological analysis of every scalp sample is recommended.”1I cannot find any published data on the exact......
Zincplex Releases Extra Strength Version For Scalp Flaking and Itching
The top rated herbal scalp shampoo releases an extra strength version. Chattanooga, TN (PRWEB) July 25, 2012 For years Zincplex has been producing an herbal alternative for people that want help with...
FDA approves Stiefel’s Sorilux Foam sNDA to treat for scalp psoriasis
Stiefel, a GSK company, today announced that the US Food and Drug Administration has approved a supplemental New Drug Application (sNDA) for Sorilux (calcipotriene) Foam, 0.005%. The sNDA expands the...
Matching PubMed Articles
Microparticulate Based Topical Delivery System of Clobetasol Propionate.
Psoriasis is a chronic, autoimmune skin disease affecting approximately 2% of the world's population. Clobetasol propionate which is a superpotent topical corticosteroid is widely used for topical tre...
Chemotherapy-induced alopecia is a commonly feared chemotherapy side effect and can be prevented using scalp cooling. Scalp metastasis is a rare site of recurrence. There is a question about whether o...
Specular light reflectance of flakes in seborrhoeic dermatitis of the scalp: a pilot study.
Seborrhoeic dermatitis and dandruff are common scalp conditions. In this study, we set out to explore a new method for rating both the severity of the scalp condition and the efficacy of scalp-care co...
Scalp psoriasis: an overview of the disease and available therapies.
The scalp is one of the regions of the body most commonly affected by psoriatic lesions. While the head represents only 10 percent of the body's surface area, the consequences of scalp psoriasis are d...
Clinical and Dermoscopic Features of 88 Scalp Nevi in 39 Children.
Background: Paediatric scalp nevi may represent a source of anxiety for practitioners and parents, as the clinical and dermoscopic features of typical nevi have yet to be defined. Prompted by conce...